Product ID:HEXANES
MSDS Date:07/01/1994
FSC:6810
NIIN:00-949-0257
MSDS Number: BWPSP

SPECTRUM CHEMICAL MFG CORP.

14422 SOUTH SAN PEDRO STREET
GARDENA, CA 90248
US

Emergency Phone: 213-516-8000/800-424-9300(CHEMTREC)

Info Phone: 213-516-8000

Preparer: C.A. EISENHARD

Cage: 63415

SPECTRUM LABORATORY PRODUCTS INC

GARDENA, CA 90248-2027 US

Telephone: 310-516-9843

Cage: 63415

HEXANE (N-HEXANE) (CERCLA)

CAS: 110-54-3

RTECS: MN9275000

Fraction By Weight: VARIES

OSHA PEL 500 PPM

ACGIH TLV: 50 PPM; 9495

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB

ISOHEXANE

CAS: 107-83-5

RTECS: SA2995000

Fraction By Weight: VARIES

3-METHYL PENTANE

CAS: 96-14-0

RTECS: SA2995500

Fraction By Weight: VARIES

NEOHEXANE

CAS: 75-83-2

RTECS: EJ9300000

Fraction By Weight: VARIES

2,3-DIMETHYLBUTANE

CAS: 79-29-8

RTECS: EJ9350000

Fraction By Weight: VARIES

LD50 LC50 Mixture:LD50 (ORAL, RAT) IS NOT KNOWN.
Routes of Entry: Inhalation:YES Skin:NO Ingestion:NO
Reports of Carcinogenicity:NTP:NO IARC:NO OSHA:NO
Health Hazards Acute and Chronic:TARGET ORGANS:EYES, SKIN, RESPIRATORY
TRACT. ACUTE- INHALATION MAY CAUSE CNS DEPRESSION. SKIN CONTACT MAY
CAUSE IRRITATION, REDNESS. MAY CAUSE EYE IRRITATION. INGESTION
CAUSES CNS DEPRESSION, VOMITING , PAIN. CHRONIC- LOSS OF DEEP
SENSORY REFLEXES, DERMATITIS, ITCHING, PAIN, CONJUNCTIVITIS, BRAIN
DAMAGE/CARDIAC ARREST.
Explanation of Carcinogenicity:NONE
Effects of Overexposure:IRRITATION, DRY SKIN, CONFUSION, HEADACHE,
DIZZINESS, LOSS OF COORDINATION, PAIN, NAUSEA, VOMITING, DERMATITIS
Medical Cond Aggravated by Exposure:INDIVIDUALS WITH PREEXISTING
DISEASES OF THE CENTRAL NERVOUS SYSTEM MAY HAVE INCREASED
SUSCEPTIVITY TO THE TOXICITY OF EXCESSIVE EXPOSURES.

First Aid:GET MEDICAL HELP FOR ALL CASES. EYES:FLUSH WITH WATER FOR AT
LEAST 15 MINUTES. HOLD EYELIDS OPEN. SKIN:WASH WITH SOAP & WATER
FOR 15 MINUTES. INHALED:REMOVE TO FRESH AIR. PROVIDE CPR/OXYGEN IF
NECESSA RY. ORAL:IF CONSCIOUS, PROVIDE GASTRIC LAVAGE/EMESIS.
MAINTAIN BLOOD PRESSURE & AIRWAY. ADMINSTRATION OF GASTRIC LAVAGE,
OXYGEN/CPR SHOULD BE PERFORMED BY QUALIFIED MEDICAL PERSONNEL.

Flash Point:-7F,-22C
Lower Limits:1.1
Upper Limits:7.5
Extinguishing Media:WATER SPRAY, CARBON DIOXIDE, HALON, FOAM/DRY
CHEMICAL. WATER SPRAY MAY BE USED TO KEEP FIRE EXPOSED CONTAINERS
COOL.
Fire Fighting Procedures:WEAR FIRE FIGHTING PROTECTIVE EQUIPMENT AND A
NIOSH-APPROVED SELF CONTAINED BREATHING APPARATUS OPERATED IN
POSITIVE PRESSURE MODE.
Unusual Fire/Explosion Hazard:VAPOR IS HEAVIER THAN AIR AND MAY TRAVEL
CONSIDERABLE DISTANCE TO A SOURCE OF IGNITION AND FLASH BACK.
CONTAINERS MAY RUPTURE DUE TO VAPOR PRESSURE BUILDUP.

Spill Release Procedures:WEAR PROTECTIVE EQUIPMENT. ELIMINATE SOURCES
OF IGNITION. VENTILATE AREA. REMOVE SPILL WITH PUMP/NON-FLAMMABLE
ABSORBENT SUCH AS SAND/CLAY. PLACE IN CONTAINER FOR DISPOSAL. WASH
SPILL SITE AFTER PICK UP IS COMPLETE. PREVENT LIQUID FROM ENTERING
SEWER
Neutralizing Agent:NOT RELEVANT

Handling and Storage Precautions:STORE IN TIGHTLY CLOSED CONTAINERS IN
VENTILATED AREA AWAY FROM IGNITION SOURCES & INCOMPATIBLES. KEEP
OUT OF REACH OF CHILDREN.
Other Precautions:AVOID BREATHING VAPORS. DO NOT GET IN EYES, ON SKIN
OR ON CLOTHING. WASH THOROUGHLY AFTER HANDLING AND BEFORE EATING OR
DRINKING. REMOVE CONTAMINATED CLOTHING PROMPTLY. LAUNDER BEFORE
REUSE.

Respiratory Protection:IF TLV IS EXCEEDED OR FOR SYMPTOMS OF OVER
EXPOSURE, WEAR NIOSH-APPROVED ORGANIC VAPOR RESPIRATOR OR
AIR-PURIFYING RESPIRATOR. IN EMERGENCY, WEAR A NIOSH-APPROVED
POSITIVE-PRESSURE SELF-CONTAINED BREA THING APPARATUS.
Ventilation:MECHANICAL (GENERAL AND/OR LOCAL EXHAUST, EXPLOSION-PROOF)
VENTILATION TO MAINTAIN EXPOSURE BELOW TLV(S).
Protective Gloves:NATURAL RUBBER, NEOPRENE
Eye Protection:SAFETY GOGGLES/FACE SHIELD
Other Protective Equipment:EYE WASH STATION & SAFETY SHOWERS SHOULD BE
AVAILABLE IN THE IMMEDIATE VICINITY OF ANY POTENTIAL EXPOSURE. LAB
COAT
Work Hygienic Practices:OBSERVE GOOD INDUSTRIAL HYGIENE PRACTICES AND
RECOMMENDED PROCEDURES.
Supplemental Safety and Health
CONSUMPTION OF ALCOHOL MAY POTENTIATE THE TOXIC EFFECTS . USE OF
STIMULANT SUCH AS EPINEPHRINE MAY INDUCE VENTICULAR FIBRILLATION.

HCC:F2
NRC/State Lic Num:NOT RELEVANT
Boiling Pt:B.P. Text:156F,69C
Melt/Freeze Pt:M.P/F.P Text:-139F,-95C
Vapor Pres:124 68F
Vapor Density:3.0
Spec Gravity:0.6603
Evaporation Rate & Reference:15.8 (N-BUTYL ACETATE=1)
Solubility in Water:0.014% @ 68F
Appearance and Odor:CLEAR, COLORLESS MOBILE LIQUID WITH A MILD GASOLINE
ODOR
Percent Volatiles by Volume:100

Stability Indicator/Materials to Avoid:YES
STRONG OXIDIZING AGENTS, CALCIUM HYPOCHLORITE, OXYGEN, PLASTICS, SODIUM
HYPOCHLORITE
Stability Condition to Avoid:HIGH HEAT, SPARKS, OPEN FLAMES AND OTHER
SOURCES OF IGNITION
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE

Waste Disposal Methods:DISPOSE OF IN ACCORDANCE WITH ALL LOCAL, STATE
AND FEDERAL REGULATIONS. MAY BE BURNED IN AN APPROVED CHEMICAL
INCINERATOR.

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.